menu trigger
menu trigger
E HËNË- E SHTUNË 8:00 - 17:00E DIEL PUSHIM+355 4 451 9080info@criostemcells.comBulevardi Zogu i ParëQëndra e biznesit TIRANA
Umbilical cord blood is a fantastic source of stem cells
Umbilical cord blood contains unique stem cells called haematopoietic stem cells; HSCs. These specialised cells can reproduce into the types of cells found in the blood. This means they can treat life-threatening blood diseases like leukaemia’s, anaemia’s and thalassemia’s. To date there are more than 85 different diseases that can be treated with HSC’s from umbilical cord blood.
As the HSC’s found in cord blood are particularly naive due to being essentially left over after the birth of your baby, this makes them highly desirable for use in stem cell transplantation as they can be transplanted with less adverse effects than other forms of stem cell treatment. They also offer a higher chance of a match to family members than cells obtained from other sources.
Collecting and storing these stem cells for your child is a once in a lifetime opportunity that is risk free, the cells are only collected after your baby is born and the umbilical cord has been cut. This ensures nothing about this procedure is dangerous for you or your baby.
Future Health Biobank has released cord blood samples for treatment in the USA, Europe and the Middle East. These samples have been used to treat conditions such as Fanconi’s Anaemia, Severe Combined Immunodeficiency (SCID) and Beta Thalassemia.
As the HSC’s found in cord blood are particularly naive due to being essentially left over after the birth of your baby, this makes them highly desirable for use in stem cell transplantation as they can be transplanted with less adverse effects than other forms of stem cell treatment. They also offer a higher chance of a match to family members than cells obtained from other sources.
Collecting and storing these stem cells for your child is a once in a lifetime opportunity that is risk free, the cells are only collected after your baby is born and the umbilical cord has been cut. This ensures nothing about this procedure is dangerous for you or your baby.
Future Health Biobank has released cord blood samples for treatment in the USA, Europe and the Middle East. These samples have been used to treat conditions such as Fanconi’s Anaemia, Severe Combined Immunodeficiency (SCID) and Beta Thalassemia.
Store your umbilical cord tissue
Cord tissue is known to be a rich source of Mesenchymal stem cells (MSCs).
Today there are around 300 ongoing clinical trials globally using MSCs to treat such condition as autism, cerebral palsy and diabetes.
Future Health will store for you multiple samples of cord tissue in separate cryogenic storage containers. These samples are frozen, ensuring that the whole tissue is available for use once treatments are available.
In addition, Future Health will store an additional sample of cord tissue for quality control purposes. This sample is thawed, the cells extracted from the tissue and cultured. This is to ensure that we only store samples that contain viable (live) cells with the proliferation capability (ability to divide) required, to ensure they will potentially be suitable for use in treatments as and when they become available.
The processes used by Future Health to store cord tissue have been shown to result in the banking of live cells. Future Health is currently undertaking further validation studies to prove that the cord tissue samples stored do contain MSCs which retain their ability to differentiate into different tissue types including bone, cartilage and fat after the samples have been frozen. Future Health is not able to guarantee that cord tissue stored contains stem cells and the number and quality of these cells.
Today there are around 300 ongoing clinical trials globally using MSCs to treat such condition as autism, cerebral palsy and diabetes.
Future Health will store for you multiple samples of cord tissue in separate cryogenic storage containers. These samples are frozen, ensuring that the whole tissue is available for use once treatments are available.
In addition, Future Health will store an additional sample of cord tissue for quality control purposes. This sample is thawed, the cells extracted from the tissue and cultured. This is to ensure that we only store samples that contain viable (live) cells with the proliferation capability (ability to divide) required, to ensure they will potentially be suitable for use in treatments as and when they become available.
The processes used by Future Health to store cord tissue have been shown to result in the banking of live cells. Future Health is currently undertaking further validation studies to prove that the cord tissue samples stored do contain MSCs which retain their ability to differentiate into different tissue types including bone, cartilage and fat after the samples have been frozen. Future Health is not able to guarantee that cord tissue stored contains stem cells and the number and quality of these cells.
Upon arriving in our lab, the cord blood bag is purified and placed in a sterile room
Cord blood is weighing and from it it’s removed small volume that is used to count the cells found in the sample.
The cord blood is placed in a centrifuge, which divides cord blood into plasma layers, stem cells, and red blood cells.
Further, two plasma vials are deposited in nitrogenous tankers in a vapor state at -190 degrees.
A small volume is taken and counted the number cells.
A freeze-dried substance is added to the sample and, further, the freezer bag is placed in a metal protective container.
The sample further cools up to -190 degrees, using a controlled freezer.
The sample is placed in nitrogen tankers, evaporated and deposited for 30 years.